Autonomix Medical (AMIX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Autonomix Medical (AMIX) is Moderate Underperform.

The composite score behind that read is -0.24, weighing +0.03 of bullish evidence against -0.45 bearish.

Autonomix Medical last closed at $3.11, -0.64% on the session.

Against the IVW growth benchmark the position is -1.44% over the forecast window.

The read is built from 12 underlying insights — 1 bullish and 11 bearish.

Agreement across those insights is 92%.

20 graded predictions for AMIX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Autonomix Medical in the 4th percentile on return on equity, where 100 is best.

Autonomix Medical is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $6.13M.

StockMap tracks Autonomix Medical as the 136th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Autonomix Medical ranks 129th of 140 in the group, against a group median of -0.03.